Skip to content

Clinical trials

Observational Glomerulosclerosis, Focal Segmental trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Phase: Observational Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20091
20101
20111
20161
20181
20194
20201
20212
20224
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Completed9
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
University of Michigan3
Assistance Publique - Hôpitaux de Paris2
Istanbul University2
Beth Israel Deaconess Medical Center1
Children's Hospital Medical Center, Cincinnati1
Christoph Aufricht1
George (Beijing) Clinical Research Co. Ltd.1
Goldfinch Bio, Inc.1
Mario Negri Institute for Pharmacological Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental27
Nephrosis, Lipoid18
Nephrotic Syndrome11
Glomerulonephritis, Membranous9
Kidney Diseases8
Glomerulonephritis, IGA7
Diabetic Nephropathies6
Proteinuria5
Glomerulonephritis3
Renal Insufficiency, Chronic3

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.